Women’s Health Diagnostics Market Size, Trends and Insights By Application (Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Prenatal Testing), By End Use (Hospital and Diagnostics Centers, Home), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- Siemens
- Carestream Health
- MEDGYN PRODUCTS INC.
- URIT MEDICAL ELECTRONIC CO. LTD
- COOK
- Others
Reports Description
As per the current market research conducted by CMI Team, the Global Womens Health Diagnostics Market is expected to record a CAGR of 7.6% from 2023 to 2032. In 2022, the market size is projected to reach a valuation of USD 25.8 Billion. By 2032, the valuation is anticipated to reach USD 45.4 Billion.
Women’s Health Diagnostics Market: Overview
The area of medicine known as women’s health is primarily concerned with the treatment and diagnosis of illnesses and ailments that have an impact on a woman’s health. Breast cancer, ovarian cancer, cervical cancer, menopause, and pregnancy are just a few of the women’s health diseases that may be detected through screening, testing, diagnosis, and monitoring.
There are several test kinds available to diagnose illnesses affecting women’s health. Medical diagnostic tools including biopsy machines, imaging and monitoring systems, mammography machines, and others aid with illness screening and diagnosis by detecting cancer, clearing obstructions, and taking pictures of inside organs. The worldwide demand for numerous health diagnostic tests has grown dramatically.
The market is now primarily driven by rising chronic and lifestyle disorders, increasing chronic illness awareness, and the high prevalence of infectious diseases including HIV and hepatitis in women throughout the world. During the projected period, this market’s expansion is anticipated to be aided by rising POC diagnostic testing adoption rates as well as an increase in the number of diagnostic and imaging facilities.
Women’s Health Diagnostics Market: COVID–19 Impact Analysis
Global economies have been significantly impacted by the COVID-19 pandemic. For several industries, COVID-19 has created a number of difficulties. International trade and travel have been hampered as more and more nations across the world have restricted travel and closed their borders in an effort to curb the coronavirus (COVID-19) epidemic since the year 2020 began.
Due to the disruption of the supply chains for the market for women’s health diagnostics, there was a temporary decline in demand as a result of the unpredictability of the global economy and capital markets. Unfavourable changes in policies and laws are hindering the expansion of this industry during the COVID-19 epidemic. The risk of COVID-19 infection is higher for breast cancer patients than for healthy persons, according to major regulatory agencies.
As a result, screening, operations, and diagnostic tests are delayed and severely constrained in hospitals and breast cancer treatment facilities. The market for diagnostics for women’s health is growing despite the low screening rates brought on by COVID-19. The delay in the detection of breast cancer also affected its treatment, which is anticipated to cause market disruption in the breast cancer treatment and diagnosis sectors.
Women’s Health Diagnostics Market: Growth Drivers
An increasing number of elderly people accelerates the market’s growth
The increase in the geriatric population promotes market growth since older individuals have diminished physiological capabilities, poorer blood circulation, and are more susceptible to chronic illnesses. Age-related sexual issues are prevalent among women.
The necessity for diagnostics for women’s health has increased along with the number of patients. Since menopause can increase the risk of developing certain medical conditions including cardiovascular disease and urinary incontinence, a significant increase in the number of women over 50 is driving the market.
Demand for efficient women’s health diagnostics is increased by infections in pregnant women.
Concerns about the accurate detection of different illnesses have been raised due to the high dangers connected with the transfer of infectious diseases to pregnant women. In order to enhance patient outcomes, top companies in the market for women’s health diagnostics are enhancing the efficacy of their laboratory testing solutions.
For instance, TORCH (toxoplasmosis, other (e.g., syphilis, HIV), rubella, cytomegalovirus (CMV), and herpes simplex virus) infections, malnutrition, and bone diseases are just a few of the laboratory testing options Siemens Healthineers, a leading global provider of medical technology, offers for women. Healthcare organizations in the women’s health diagnostics market are seizing possibilities in infectious disease testing and diagnostic laboratory testing, both of which are predicted to see strong growth over the forecast period.
The need for effective treatment options in women’s health diagnostics is being fueled by the rising occurrence of infections that result in miscarriage and birth abnormalities in newborns.
Women’s Health Diagnostics Market: Segmentation Analysis
The women’s health diagnostics market is segmented into application and end use. Based on application, the market for cancer testing segment is estimated to lead the market during the forecast period. Due to the development of highly accurate, technologically advanced hybrid imaging tools, cancer testing dominated the market in 2021. The market is expected to increase as a result of numerous partnerships between major firms, governments, and other organizations. These partnerships aim to improve patients’ access to diagnostics for a range of disorders.
By end use, the hospitals and diagnostics centers segment is anticipated to dominate the market during the forecast period. In 2021, the sector of hospitals and diagnostics centers contributed the most to the market. Hospitalizations have increased significantly as a result of the growth in breast and ovarian cancer incidence. Since they are frequently the first choice for patients for the detection of cancer, infectious diseases, and osteoporosis, among other things, the industry is anticipated to continue its market position through 2030.
Throughout the anticipated period, the home category is anticipated to grow quickly as market participants expand their investments in the commercialization of portable and point-of-care devices. Additionally, increased consumer awareness of home diagnostic tools is anticipated to fuel business expansion.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 27.7 Billion |
| Projected Market Size in 2032 | USD 45.4 Billion |
| Market Size in 2022 | USD 25.8 Billion |
| CAGR Growth Rate | 7.6% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Application, End Use and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Key Insights:
- Based on application segmentation, the cancer testing segment is estimated to hold the largest market share during the forecast period.
- Based on end use segmentation, the hospital and diagnostics centers segment in the women’s health diagnostics market is the leading revenue-generating category during the forecast period.
- On the basis of geography/region, the North America region was the leading revenue generator in 2021.
Recent Development
- February 2021: SmartBreast has purchased the molecular breast imaging assets from GE Healthcare for an unknown sum. As part of the agreement, the business obtained the designs for MBI scanners, the Discovery NM750B, as well as several other production tools and associated patents.
- November 2020: A partnership between RadNet and Hologic Inc. has been announced in an effort to accelerate the creation of artificial intelligence solutions for breast health. Research and development, data exchange, and an update to Radnet’s fleet of Hologic mammography systems are all goals of the cooperation.
Regional Landscape
Throughout the projection period, North America is expected to continue to be among the most alluring markets and this region is accounted for the majority revenue share in the market.
The substantial market share of this sector may be due to the rising incidence of cancer in women, the growing emphasis on establishing a presence in this area among producers of diagnostic devices for women’s health, and the rising demand for fertility testing monitors. During the projected period, it is also anticipated that the growing popularity of POC diagnostics and PST procedures would fuel the expansion of this regional market.
Due to the region’s expanding healthcare infrastructure, considerable growth in the market for women’s health diagnostics is also anticipated. Additionally, the government’s programs include a rise in women’s employment involvement. Additionally, it is projected that in the upcoming years, increased awareness of women’s health diseases would fuel the expansion of the region’s market for women’s health diagnostics.
Competitive Landscape
Our report offers both quantitative and qualitative insights into the WebRTC market and major development initiatives adopted by the key players. Further, it offers competitive details and market share analysis. The report further includes relevant financial information, products and services offered, SWOT analysis, and recent developments of the players profiled.
List of the prominent players in the global women’s health diagnostics market:
- Siemens
- Carestream Health
- MEDGYN PRODUCTS INC.
- URIT MEDICAL ELECTRONIC CO. LTD
- COOK
- Cardinal Health
- NeuroLogica Corp.
- Shimadzu Corporation
- PerkinElmer Inc.
- General Electric Company
- Hologic Inc.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Abbott
- BD
- Danaher
- Sysmex Corporation
- Hitachi Ltd.
- Others
The global Women’s health diagnostics market is segmented as follows:
By Application
- Cancer
- Infectious Disease Testing
- Osteoporosis Testing
- Pregnancy and Fertility Testing
- Prenatal Testing
By End Use
- Hospital and Diagnostics Centers
- Home
By Region
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Womens Health Diagnostics Market, (2024 – 2033) (USD Billion)
- 2.2 Global Womens Health Diagnostics Market : snapshot
- Chapter 3. Global Womens Health Diagnostics Market – Industry Analysis
- 3.1 Womens Health Diagnostics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing number of elderly people accelerate the market’s growth
- 3.2.2 Demand for efficient women’s health diagnostics is increased by infections in pregnant women.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Application
- 3.7.2 Market attractiveness analysis By End Use
- Chapter 4. Global Womens Health Diagnostics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Womens Health Diagnostics Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Womens Health Diagnostics Market – Application Analysis
- 5.1 Global Womens Health Diagnostics Market overview: By Application
- 5.1.1 Global Womens Health Diagnostics Market share, By Application, 2022 and – 2033
- 5.2 Cancer
- 5.2.1 Global Womens Health Diagnostics Market by Cancer, 2024 – 2033 (USD Billion)
- 5.3 Infectious Disease Testing
- 5.3.1 Global Womens Health Diagnostics Market by Infectious Disease Testing, 2024 – 2033 (USD Billion)
- 5.4 Osteoporosis Testing
- 5.4.1 Global Womens Health Diagnostics Market by Osteoporosis Testing, 2024 – 2033 (USD Billion)
- 5.5 Pregnancy and Fertility Testing
- 5.5.1 Global Womens Health Diagnostics Market by Pregnancy and Fertility Testing, 2024 – 2033 (USD Billion)
- 5.6 Prenatal Testing
- 5.6.1 Global Womens Health Diagnostics Market by Prenatal Testing, 2024 – 2033 (USD Billion)
- 5.1 Global Womens Health Diagnostics Market overview: By Application
- Chapter 6. Global Womens Health Diagnostics Market – End Use Analysis
- 6.1 Global Womens Health Diagnostics Market overview: By End Use
- 6.1.1 Global Womens Health Diagnostics Market share, By End Use, 2022 and – 2033
- 6.2 Hospital and Diagnostics Centers
- 6.2.1 Global Womens Health Diagnostics Market by Hospital and Diagnostics Centers, 2024 – 2033 (USD Billion)
- 6.3 Home
- 6.3.1 Global Womens Health Diagnostics Market by Home, 2024 – 2033 (USD Billion)
- 6.1 Global Womens Health Diagnostics Market overview: By End Use
- Chapter 7. Womens Health Diagnostics Market – Regional Analysis
- 7.1 Global Womens Health Diagnostics Market Regional Overview
- 7.2 Global Womens Health Diagnostics Market Share, by Region, 2022 & – 2033 (USD Billion)
- 7.3. North America
- 7.3.1 North America Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.3.1.1 North America Womens Health Diagnostics Market, by Country, 2024 – 2033 (USD Billion)
- 7.3.1 North America Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.4 North America Womens Health Diagnostics Market, by Application, 2024 – 2033
- 7.4.1 North America Womens Health Diagnostics Market, by Application, 2024 – 2033 (USD Billion)
- 7.5 North America Womens Health Diagnostics Market, by End Use, 2024 – 2033
- 7.5.1 North America Womens Health Diagnostics Market, by End Use, 2024 – 2033 (USD Billion)
- 7.6. Europe
- 7.6.1 Europe Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.6.1.1 Europe Womens Health Diagnostics Market, by Country, 2024 – 2033 (USD Billion)
- 7.6.1 Europe Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.7 Europe Womens Health Diagnostics Market, by Application, 2024 – 2033
- 7.7.1 Europe Womens Health Diagnostics Market, by Application, 2024 – 2033 (USD Billion)
- 7.8 Europe Womens Health Diagnostics Market, by End Use, 2024 – 2033
- 7.8.1 Europe Womens Health Diagnostics Market, by End Use, 2024 – 2033 (USD Billion)
- 7.9. Asia Pacific
- 7.9.1 Asia Pacific Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.9.1.1 Asia Pacific Womens Health Diagnostics Market, by Country, 2024 – 2033 (USD Billion)
- 7.9.1 Asia Pacific Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.10 Asia Pacific Womens Health Diagnostics Market, by Application, 2024 – 2033
- 7.10.1 Asia Pacific Womens Health Diagnostics Market, by Application, 2024 – 2033 (USD Billion)
- 7.11 Asia Pacific Womens Health Diagnostics Market, by End Use, 2024 – 2033
- 7.11.1 Asia Pacific Womens Health Diagnostics Market, by End Use, 2024 – 2033 (USD Billion)
- 7.12. Latin America
- 7.12.1 Latin America Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.12.1.1 Latin America Womens Health Diagnostics Market, by Country, 2024 – 2033 (USD Billion)
- 7.12.1 Latin America Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.13 Latin America Womens Health Diagnostics Market, by Application, 2024 – 2033
- 7.13.1 Latin America Womens Health Diagnostics Market, by Application, 2024 – 2033 (USD Billion)
- 7.14 Latin America Womens Health Diagnostics Market, by End Use, 2024 – 2033
- 7.14.1 Latin America Womens Health Diagnostics Market, by End Use, 2024 – 2033 (USD Billion)
- 7.15. The Middle-East and Africa
- 7.15.1 The Middle-East and Africa Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.15.1.1 The Middle-East and Africa Womens Health Diagnostics Market, by Country, 2024 – 2033 (USD Billion)
- 7.15.1 The Middle-East and Africa Womens Health Diagnostics Market, 2024 – 2033 (USD Billion)
- 7.16 The Middle-East and Africa Womens Health Diagnostics Market, by Application, 2024 – 2033
- 7.16.1 The Middle-East and Africa Womens Health Diagnostics Market, by Application, 2024 – 2033 (USD Billion)
- 7.17 The Middle-East and Africa Womens Health Diagnostics Market, by End Use, 2024 – 2033
- 7.17.1 The Middle-East and Africa Womens Health Diagnostics Market, by End Use, 2024 – 2033 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Siemens
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Carestream Health
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 MEDGYN PRODUCTS INC.
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 URIT MEDICAL ELECTRONIC CO. LTD
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 COOK
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Cardinal Health
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 NeuroLogica Corp.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Shimadzu Corporation
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 PerkinElmer Inc.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 General Electric Company
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Hologic Inc.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Abbott
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 BD
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Danaher
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 Sysmex Corporation
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Hitachi Ltd.
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.18 Others
- 8.18.1 Overview
- 8.18.2 Financials
- 8.18.3 Product Portfolio
- 8.18.4 Business Strategy
- 8.18.5 Recent Developments
- 8.1 Siemens
List Of Figures
Figures No 1 to 21
List Of Tables
Tables No 1 to 52
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2030
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Players
- Siemens
- Carestream Health
- MEDGYN PRODUCTS INC.
- URIT MEDICAL ELECTRONIC CO. LTD
- COOK
- Cardinal Health
- NeuroLogica Corp.
- Shimadzu Corporation
- PerkinElmer Inc.
- General Electric Company
- Hologic Inc.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- Abbott
- BD
- Danaher
- Sysmex Corporation
- Hitachi Ltd.
- Others
FAQs
“North America” region will lead the Global Women’s Health Diagnostics Market during the forecast period 2023 to 2032.
The key factors driving the Market are Increasing number of elderly people accelerate the market’s growth And Demand for efficient women’s health diagnostics is increased by infections in pregnant women.
The key players operating in the Women’s Health Diagnostics Market are Siemens,Carestream Health,MEDGYN PRODUCTS INC.,URIT MEDICAL ELECTRONIC CO. LTD,COOK,Cardinal Health,NeuroLogica Corp.,Shimadzu Corporation,PerkinElmer Inc.,General Electric Company,Hologic Inc.,Shenzhen Mindray Bio-Medical Electronics Co. Ltd.,Abbott,BD,Danaher,Sysmex Corporation,Hitachi Ltd.,Others.
The Global Women’s Health Diagnostics Market is expanding growth with a CAGR of approximately 7.6% during the forecast period (2023 to 2032).
The Global Women’s Health Diagnostics Market size was valued at USD 25.8 Billion in 2022 and it is projected to reach around USD 45.4 Billion by 2032.